Get started
Author

Tadayoshi Hashimoto

Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer
2019 · Tadayoshi Hashimoto, Yukinori Kurokawa, et al. · Gastric Cancer · 70
PDF
The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance
2019 · Tadayoshi Hashimoto, Tomoki Makino, et al. · Annals of Surgery · 59
Surgical Treatment of Gastroesophageal Junction Cancer
2018 · Tadayoshi Hashimoto, Yukinori Kurokawa, et al. · Journal of the Korean Gastric Cancer Association · 45
PDF
Postoperative Long‐Term Outcomes in Elderly Patients with Gastric Cancer and Risk Factors for Death from Other Diseases
2019 · Tadayoshi Hashimoto, Yukinori Kurokawa, et al. · World Journal of Surgery · 43
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
2024 · Tadayoshi Hashimoto, Yoshiaki Nakamura, et al. · International Journal of Clinical Oncology · 32
PDF
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
2024 · Tadayoshi Hashimoto, Yoshiaki Nakamura, et al. · Cancer Discovery · 29
Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus
2019 · Tadayoshi Hashimoto, Tomoki Makino, et al. · Oncology Letters · 25
PDF
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential
2024 · Tadayoshi Hashimoto, Yoshiaki Nakamura, et al. · Cancer Science · 21
PDF
Clinical significance of chromatin remodeling factor CHD5 expression in gastric cancer
2019 · Tadayoshi Hashimoto, Yukinori Kurokawa, et al. · Oncology Letters · 19
PDF
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer
2024 · Amane Jubashi, Izuma Nakayama, et al. · Gastric Cancer · 16
PDF
Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications
2008 · T. Hashimoto, Y. Kajiyama, et al. · Diseases of the Esophagus · 16
PDF
Japan society of clinical oncology position paper on appropriate clinical use of molecular residual disease (MRD) testing
2025 · Shin Kobayashi, Yoshiaki Nakamura, et al. · International Journal of Clinical Oncology · 15
PDF
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer
2023 · Tadayoshi Hashimoto, Izuma Nakayama, et al. · Future Oncology · 15
Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma
2025 · S. Sato, S.L. Rhodes, et al. · ESMO Open · 14
PDF
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience
2024 · U. Okazaki, I. Nakayama, et al. · ESMO Gastrointestinal Oncology · 14
PDF
Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer
2023 · Akira Ouchi, Ryo Sadachi, et al. · Annals of Surgery · 13
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR ‐ SCREEN ‐2 Study
2025 · Tadayoshi Hashimoto, Naoko Iida, et al. · Cancer Science · 12
PDF
Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device
2017 · Yuki Nakamura, Koichi Toda, et al. · Journal of Artificial Organs · 12
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
2025 · Marco Maria Germani, Beatrice Borelli, et al. · Journal of Clinical Oncology · 11
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study)
2024 · Naoki Ikenaga, Tadayoshi Hashimoto, et al. · BMC Cancer · 11
PDF
Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010)
2023 · Tadayoshi Hashimoto, Shunsuke Tsukamoto, et al. · BJS Open · 11
PDF
What is the most useful body composition parameter for predicting toxicities of preoperative chemotherapy for gastric cancer?
2019 · Tadayoshi Hashimoto, Yukinori Kurokawa, et al. · Surgery Today · 11
Prognostic Impact of Thoracic Duct Resection in Patients Who Underwent Transthoracic Esophagectomy Following Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: Exploratory Analysis of JCOG1109
2024 · Satoru Matsuda, Hiroya Takeuchi, et al. · Annals of Surgical Oncology · 9
Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials.
2025 · Yoshinori Kagawa, Hiroya Taniguchi, et al. · Journal of Clinical Oncology · 8
Circulating Tumor DNA Assessment to Predict Risk of Recurrence After Surgery in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
2025 · Shogo Takei, Daisuke Kotani, et al. · Annals of Surgery · 8
Works count: 169
Citation count: 656
H-index: 14
I10-index: 22
Year
Topic
Type